After almost two decades with the company herself, Sherry interviewed several of her colleagues about what made them choose to work at ACD/Labs, if they enjoy it here (obviously!), and what makes them stay. Read on for a look at the employee satisfaction at ACD/Labs.
Andrew Anderson, VP of Innovation & Informatics Strategy, recently spoke with Scientific Computing World about some of the challenges associated with data standardization and how the value of data can be realized. Here’s an overview of what he covered...
Benchtop NMR instruments are becoming an indispensable addition to the analytical laboratory for their ability to make NMR spectroscopy more accessible to chemists. Here we discuss the newer applications of benchtop NMR including material testing, flow chemistry and use in teaching.
A software demonstration is a great opportunity to learn about the features and capabilities of the software you are interested in and find out if it meets your needs. A successful demo helps you make an informed decision about whether the software is right for your specific challenges. But, how can your team prepare for a technical software demo to get the most value out of it?
Andrew Anderson recently shared his insight on workflow automation trends in a Pharma Manufacturing article. He emphasizes taking a quality-first approach throughout the automation, digitalization, and analysis processes to truly realize the benefits of Industry 4.0. Here are some of the highlights.
When Widener University switched to online teaching, Chemistry Professor Scott van Bramer turned to online tools as a way to continue educating his students. ACD/Method Selection Suite provided the answer to help his students run virtual experiments, and exposed them to the type of software they will see in their eventual workplaces.
Richard Lee reflects on how biotechnology organizations can use their historical data to address real chemistry world problems; especially during this time when more and more scientists are working remotely.
Norman Aubry, a long time user of our NMR software, shares his experiences with ACD/Labs over the past 25+ years.
At a time when the world is watching and expecting lightning fast results from drug development for SARS-COV-2 therapies I am reflecting on the impediments drug development teams face in releasing an antiviral drug quickly while keeping safety and quality at the forefront.
Andrew Anderson shares some guidelines on how our software can support scientists shifting to a remote working environment.